What is GPx?
GPx is dedicated to enhancing the lives of individuals managing chronic diseases. The company leverages personalized and predictive innovations designed for patient ease of use and to empower clinicians in delivering optimal care. This strategic focus positions GPx at the forefront of digital health solutions, aiming to transform the landscape of chronic condition management through advanced technology and data-driven insights.
How much funding has GPx raised?
GPx has raised a total of $3.3M across 1 funding round:
Angel/Seed
$3.3M
Angel/Seed (2022): $3.3M with participation from Hiroaki Kitano, The D4V, and Pete Moran
Key Investors in GPx
Hiroaki Kitano
Hiroaki Kitano is an individual investor participating in the funding round.
The D4V
D4V (Design for Ventures) is a Japanese venture capital firm focused on empowering startups with design, insight, capital, and mentorship to achieve global success.
Pete Moran
Pete Moran's investment focus appears to be within contemporary family entertainment, with a portfolio that includes themed spaces designed for diverse family interests and relaxation.
What's next for GPx?
The substantial enterprise-level backing indicates a pivotal growth phase for GPx. This infusion of capital is expected to accelerate product development, expand market reach, and further refine its predictive health technologies. The company is poised to scale its operations, solidifying its position as a key player in the chronic disease management sector and driving innovation in personalized healthcare solutions.
See full GPx company page
